Immunogenicity of live attenuated hepatitis A vaccine in overweight and obese children/adolescent/young adult

Phase 4

Recruiting

• Conditions: Overweight or obesity; Hepatitis A vaccine, immunogenicity, overweight, obesity

• Registration Number: TCTR20191230001
• Lead Sponsor: BIOGENETECH CO., LTD.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-12-30
• Study Completion: 2020-01-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

- Normal weight
- Overweight or obese

Exclusion Criteria

- Persons who are immunized with hepatitis A vaccine
- Persons with immunodeficiency
- Person who receive immunosuppressive drugs

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The immunogenicity of HAV vaccine 8 weeks post vaccination Serology

Secondary Outcome Measures

Name	Time	Method
Factors associated with impaired immunogenicity to HAV vaccine Day of vaccination Body mass index, signs of insulin resistance